{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:25:34Z","timestamp":1789561534923,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Cardiac rehabilitation reduces mortality and morbidity rate of patients with coronary artery diseases (CAD); however, acute exercise stimulation may also increase the thrombotic risk through platelet activation. Studies on the effects of cardiac rehabilitation on platelet function have been sparse.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 28 patients (24 men and 4 women; average age\u2009=\u200954.6\u2009\u00b1\u20098\u00a0years old) with stable CAD were enrolled in this study and divided into Aspirin-treated (n\u2009=\u200911; Aspirin group) and dual-antiplatelet-treated group (DAPT group; n\u2009=\u200917). Symptom-limited cardiopulmonary exercise test (CPET) with a cycle ergometer was performed on all the patients. Before and after CPET, platelet function was evaluated using light transmission aggregometry and whole blood flow cytometry.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>All patients completed the CPET without provoked cardiac events, and the mean value of peak oxygen uptake (Peak Vo<jats:sub>2<\/jats:sub>) was 19.3\u2009\u00b1\u20093\u00a0ml\/(kg\u00a0min). Prior to CPET, platelet aggregation was significantly suppressed in DAPT group compared to Aspirin group (43.0\u2009\u00b1\u200921.5 vs. 72.9\u2009\u00b1\u20097.5, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). CPET promoted platelet aggregation in Aspirin group (72.9\u2009\u00b1\u20097.5 vs. 80.9\u2009\u00b1\u20097.6, <jats:italic>p<\/jats:italic>\u2009=\u20090.005) and DAPT group (43.0\u2009\u00b1\u200921.5 vs. 50.1\u2009\u00b1\u200920.9, <jats:italic>p<\/jats:italic>\u2009=\u20090.010), and platelet count was increased in Aspirin (210.9\u2009\u00b1\u200954.6 vs. 227.5\u2009\u00b1\u200958.1, <jats:italic>p<\/jats:italic>\u2009=\u20090.001) and DAPT group (217.5\u2009\u00b1\u200963.8 vs. 229.7\u2009\u00b1\u200963.7, <jats:italic>p<\/jats:italic>\u2009=\u20090.001). However, the expression levels of CD62p and PAC-1 were not affected by CPET in both groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Symptom-limited CPET enhanced platelet aggregation in patients with CAD despite treatment with antiplatelet, mainly via platelet count augmentation, but not through single platelet activation.<\/jats:p>\n                <jats:p><jats:italic>Trial registration<\/jats:italic>: Effects of high intensity interval training versus moderate intensity continue training in cardiac rehabilitation on platelet function of patients with coronary heart diseases: a exploratory randomized controlled trial.<\/jats:p>\n                <jats:p>ChiCTR-INR-17010717. Registered 23 February 2017, <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.chictr.org.cn\/edit.aspx?pid=18206&amp;htm=4\">https:\/\/www.chictr.org.cn\/edit.aspx?pid=18206&amp;htm=4<\/jats:ext-link>.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12872-022-02486-z","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T13:38:28Z","timestamp":1646401108000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Influence of cardiopulmonary exercise test on platelet function in patients with coronary artery diseases on antiplatelet therapy"],"prefix":"10.1186","volume":"22","author":[{"given":"Chun","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhua","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zong","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,4]]},"reference":[{"key":"2486_CR1","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1177\/2047487312449597","volume":"21","author":"MF Piepoli","year":"2014","unstructured":"Piepoli MF, Corr\u00e0 U, Adamopoulos S, et al. Secondary prevention in the clinical management of patients with cardiovascular diseases. Core components, standards and outcome measures for referral and delivery: a policy statement from the cardiac rehabilitation section of the European Association for Cardiovascular Prevention & Rehabilitation. Endorsed by the Committee for Practice Guidelines of the European Society of Cardiology. Eur J Prev Cardiol. 2014;21:664\u201381.","journal-title":"Eur J Prev Cardiol"},{"key":"2486_CR2","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.pcad.2016.08.004","volume":"59","author":"SL Grace","year":"2016","unstructured":"Grace SL, Turk-Adawi KI, Contractor A, et al. Cardiac rehabilitation delivery model for low-resource settings an International Council of Cardiovascular Prevention and Rehabilitation Consensus Statement. Prog Cardiovasc Dis. 2016;59:303\u201322.","journal-title":"Prog Cardiovasc Dis"},{"issue":"12","key":"2486_CR3","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3390\/jcm7120514","volume":"7","author":"NN Kabboul","year":"2018","unstructured":"Kabboul NN, Tomlinson G, Francis TA, et al. Comparative effectiveness of the core components of cardiac rehabilitation on mortality and morbidity: a systematic review and network meta-analysis. J Clin Med. 2018;7(12):514.","journal-title":"J Clin Med"},{"key":"2486_CR4","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1056\/NEJM199312023292301","volume":"329","author":"MA Mittleman","year":"1993","unstructured":"Mittleman MA, Maclure M, Tofler GH, Muller JE, Goldberg RJ, Muller JE. Triggering of acute myocardial infarction by heavy physical exertion. Protection against triggering by regular exertion. Determinants of Myocardial Infarction Onset Study Investigators. N Engl J Med. 1993;329:1677\u201383.","journal-title":"N Engl J Med"},{"key":"2486_CR5","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1056\/NEJM200103153441114","volume":"344","author":"S Kochlatyi","year":"2001","unstructured":"Kochlatyi S, Mattana J. Triggering of sudden death from cardiac causes by vigorous exertion. N Engl J Med. 2001;344:854\u20135.","journal-title":"N Engl J Med"},{"key":"2486_CR6","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1001\/jama.281.10.921","volume":"281","author":"AP Burke","year":"1999","unstructured":"Burke AP, Farb A, Malcom GT, Liang Y, Smialek JE, Virmani R. Plaque rupture and sudden death related to exertion in men with coronary artery disease. JAMA. 1999;281:921\u20136.","journal-title":"JAMA"},{"key":"2486_CR7","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1161\/CIR.0b013e3181e52e69","volume":"122","author":"GJ Balady","year":"2010","unstructured":"Balady GJ, Arena R, Sietsema K, et al. Clinician\u2019s Guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association. Circulation. 2010;122:191\u2013225.","journal-title":"Circulation"},{"key":"2486_CR8","doi-asserted-by":"publisher","first-page":"100583","DOI":"10.1016\/j.blre.2019.05.007","volume":"37","author":"M Kannan","year":"2019","unstructured":"Kannan M, Ahmad F, Saxena R. Platelet activation markers in evaluation of thrombotic risk factors in various clinical settings. Blood Rev. 2019;37:100583.","journal-title":"Blood Rev"},{"key":"2486_CR9","doi-asserted-by":"publisher","first-page":"165078","DOI":"10.1155\/2015\/165078","volume":"2015","author":"S Heber","year":"2015","unstructured":"Heber S, Volf I. Effects of physical (in)activity on platelet function. Biomed Res Int. 2015;2015:165078.","journal-title":"Biomed Res Int"},{"key":"2486_CR10","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1093\/oxfordjournals.eurheartj.a015346","volume":"18","author":"NH Wall\u00e9n","year":"1997","unstructured":"Wall\u00e9n NH, Held C, Rehnqvist N, et al. Effects of mental and physical stress on platelet function in patients with stable angina pectoris and healthy controls. Eur Heart J. 1997;18:807\u201315.","journal-title":"Eur Heart J"},{"key":"2486_CR11","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.thromres.2006.05.003","volume":"119","author":"W Kuliczkowski","year":"2007","unstructured":"Kuliczkowski W, Kobusiak-Prokopowicz M, Prajs I, et al. Aspirin failure course during exercise and its connection with soluble CD40L. Thromb Res. 2007;119:679\u201386.","journal-title":"Thromb Res"},{"key":"2486_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11239-005-2318-1","volume":"20","author":"B Pamukcu","year":"2005","unstructured":"Pamukcu B, Oflaz H, Acar RD, et al. The role of exercise on platelet aggregation in patients with stable coronary artery disease: exercise induces aspirin resistant platelet activation. J Thromb Thrombolysis. 2005;20:17\u201322.","journal-title":"J Thromb Thrombolysis"},{"key":"2486_CR13","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.thromres.2007.01.009","volume":"120","author":"C Aurigemma","year":"2007","unstructured":"Aurigemma C, Fattorossi A, Sestito A, et al. Relationship between changes in platelet reactivity and changes in platelet receptor expression induced by physical exercise. Thromb Res. 2007;120:901\u20139.","journal-title":"Thromb Res"},{"key":"2486_CR14","doi-asserted-by":"publisher","first-page":"e24932","DOI":"10.1097\/MD.0000000000024932","volume":"100","author":"M Chunhua","year":"2021","unstructured":"Chunhua M, Yanhui W, Zong Y, et al. Influence of exercise test on platelet function in patients with coronary arterial disease: a systematic review. Medicine. 2021;100:e24932.","journal-title":"Medicine"},{"key":"2486_CR15","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1055\/s-0035-1564834","volume":"42","author":"M Lordkipanidz\u00e9","year":"2016","unstructured":"Lordkipanidz\u00e9 M. Platelet function tests. Semin Thromb Hemost. 2016;42:258\u201367.","journal-title":"Semin Thromb Hemost"},{"key":"2486_CR16","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1055\/s-0035-1570082","volume":"42","author":"S Ramstr\u00f6m","year":"2016","unstructured":"Ramstr\u00f6m S, S\u00f6dergren AL, Tynng\u00e5rd N, Lindahl TL. Platelet function determined by flow cytometry: new perspectives. Semin Thromb Hemost. 2016;42:268\u201381.","journal-title":"Semin Thromb Hemost"},{"key":"2486_CR17","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1016\/j.jtcvs.2014.11.002","volume":"149","author":"SD Fihn","year":"2015","unstructured":"Fihn SD, Blankenship JC, Alexander KP, Society of Thoracic Surgeons, et al. 2014 ACC\/AHA\/AATS\/PCNA\/SCAI\/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Thorac Cardiovasc Surg. 2015;149:e5\u201323.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2486_CR18","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1161\/CIRCULATIONAHA.109.192520","volume":"119","author":"J Myers","year":"2009","unstructured":"Myers J, Arena R, Franklin B, et al. Recommendations for clinical exercise laboratories: a scientific statement from the American Heart Association. Circulation. 2009;119:3144\u201361.","journal-title":"Circulation"},{"key":"2486_CR19","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1161\/01.CIR.0000034670.06526.15","volume":"106","author":"RJ Gibbons","year":"2002","unstructured":"Gibbons RJ, Balady GJ, Bricker JT, et al. ACC\/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Circulation. 2002;106:1883\u201392.","journal-title":"Circulation"},{"key":"2486_CR20","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/S0735-1097(97)00150-2","volume":"30","author":"RJ Gibbons","year":"1997","unstructured":"Gibbons RJ, Balady GJ, Beasley JW, et al. ACC\/AHA Guidelines for Exercise Testing. A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). J Am Coll Cardiol. 1997;30:260\u2013311.","journal-title":"J Am Coll Cardiol"},{"key":"2486_CR21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11010-017-2955-7","volume":"430","author":"A Morel","year":"2017","unstructured":"Morel A, Rywaniak J, Bijak M, Miller E, Niwald M, Saluk J. Flow cytometric analysis reveals the high levels of platelet activation parameters in circulation of multiple sclerosis patients. Mol Cell Biochem. 2017;430:69\u201380.","journal-title":"Mol Cell Biochem"},{"key":"2486_CR22","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1055\/a-0631-3302","volume":"39","author":"S Brunner","year":"2018","unstructured":"Brunner S, Rizas K, Hamm W, Mehr M, Lackermair K. Effect of physical exercise on platelet reactivity in patients with dual antiplatelet therapy. Int J Sports Med. 2018;39:646\u201352.","journal-title":"Int J Sports Med"},{"key":"2486_CR23","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1161\/01.CIR.88.4.1502","volume":"88","author":"AS Kestin","year":"1993","unstructured":"Kestin AS, Ellis PA, Barnard MR, Errichetti A, Rosner BA, Michelson AD. Effect of strenuous exercise on platelet activation state and reactivity. Circulation. 1993;88:1502\u201311.","journal-title":"Circulation"},{"key":"2486_CR24","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1160\/TH07-05-0323","volume":"98","author":"C Perneby","year":"2007","unstructured":"Perneby C, Wall\u00e9n NH, Hofman-Bang C, et al. Effect of clopidogrel treatment on stress-induced platelet activation and myocardial ischemia in aspirin-treated patients with stable coronary artery disease. Thromb Haemost. 2007;98:1316\u201322.","journal-title":"Thromb Haemost"},{"key":"2486_CR25","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1161\/01.CIR.100.13.1374","volume":"100","author":"N Li","year":"1999","unstructured":"Li N, Wall\u00e9n NH, Hjemdahl P. Evidence for prothrombotic effects of exercise and limited protection by Aspirin. Circulation. 1999;100:1374\u20139.","journal-title":"Circulation"},{"key":"2486_CR26","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.thromres.2004.06.004","volume":"114","author":"C Perneby","year":"2004","unstructured":"Perneby C, Wall\u00e9n NH, Hu H, Li N, Hjemdahl P. Prothrombotic responses to exercise are little influenced by clopidogrel treatment. Thromb Res. 2004;114:235\u201343.","journal-title":"Thromb Res"},{"key":"2486_CR27","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0049-3848(99)00008-0","volume":"94","author":"M M\u00f6ckel","year":"1999","unstructured":"M\u00f6ckel M, Ulrich NV, R\u00f6cker L, et al. Exhaustive cycle exercise induces CD62p expression, coagulation, and fibrinolysis activation in ultraendurance athletes. Thromb Res. 1999;94:263\u20139.","journal-title":"Thromb Res"},{"key":"2486_CR28","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1136\/bjsm.2008.053306","volume":"44","author":"EE Peat","year":"2010","unstructured":"Peat EE, Dawson M, McKenzie A, Hillis WS. The effects of acute dynamic exercise on haemostasis in first class Scottish football referees. Br J Sports Med. 2010;44:573\u20138.","journal-title":"Br J Sports Med"},{"key":"2486_CR29","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1253\/circj.CJ-66-0094","volume":"78","author":"JCS Joint Working Group","year":"2014","unstructured":"JCS Joint Working Group. Guidelines for rehabilitation in patients with cardiovascular disease (JCS 2012). Circ J. 2014;78:2022\u201393.","journal-title":"Circ J"},{"key":"2486_CR30","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/j.1600-0609.1984.tb02172.x","volume":"32","author":"KG Schmidt","year":"1984","unstructured":"Schmidt KG, Rasmussen JW. Exercise-induced changes in the in vivo distribution of 111In-labelled platelets. Scand J Haematol. 1984;32:159\u201366.","journal-title":"Scand J Haematol"},{"key":"2486_CR31","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/j.1475-097X.2012.01156.x","volume":"33","author":"D Bakovic","year":"2013","unstructured":"Bakovic D, Pivac N, Eterovic D, et al. The effects of low-dose epinephrine infusion on spleen size, central and hepatic circulation and circulating platelets. Clin Physiol Funct Imaging. 2013;33:30\u20137.","journal-title":"Clin Physiol Funct Imaging"},{"key":"2486_CR32","doi-asserted-by":"publisher","first-page":"n1332","DOI":"10.1136\/bmj.n1332","volume":"373","author":"M Valgimigli","year":"2021","unstructured":"Valgimigli M, Gragnano F, Branca M, et al. P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials. BMJ. 2021;373:n1332.","journal-title":"BMJ"},{"key":"2486_CR33","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ijcard.2021.10.138","volume":"345","author":"A Cesaro","year":"2021","unstructured":"Cesaro A, Gragnano F, Calabr\u00f2 P, et al. Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: insights from the START-ANTIPLATELET registry. Int J Cardiol. 2021;345:7\u201313.","journal-title":"Int J Cardiol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-022-02486-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-022-02486-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-022-02486-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T13:40:00Z","timestamp":1646401200000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-022-02486-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,4]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2486"],"URL":"https:\/\/doi.org\/10.1186\/s12872-022-02486-z","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,4]]},"assertion":[{"value":"11 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was in compliance with the Declaration of Helsinki and the study protocol was approved by the Ethics Committee of Beijing First Hospital of Integrated Chinese and Western Medicine. Written informed consent was obtained from each participating patient at the time of enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"87"}}